KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Revenue (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Revenue for 11 consecutive years, with $708.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 32.03% year-over-year to $708.4 million, compared with a TTM value of $708.4 million through Dec 2025, down 66.41%, and an annual FY2025 reading of $2.5 billion, up 19.97% over the prior year.
  • Revenue was $708.4 million for Q4 2025 at Medpace Holdings, up from $536.6 million in the prior quarter.
  • Across five years, Revenue topped out at $708.4 million in Q4 2025 and bottomed at $260.0 million in Q1 2021.
  • Average Revenue over 5 years is $429.7 million, with a median of $434.1 million recorded in 2023.
  • The sharpest move saw Revenue soared 35.76% in 2021, then increased 7.66% in 2024.
  • Year by year, Revenue stood at $308.6 million in 2021, then grew by 27.72% to $394.1 million in 2022, then grew by 26.47% to $498.4 million in 2023, then rose by 7.66% to $536.6 million in 2024, then skyrocketed by 32.03% to $708.4 million in 2025.
  • Business Quant data shows Revenue for MEDP at $708.4 million in Q4 2025, $536.6 million in Q4 2024, and $533.3 million in Q3 2024.